First Clinical Candidate Developed using HUB Organoids® and High Content Screening Targets Cancer Stem Cells in Solid Tumors, Published in Nature Cancer

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


https://blog.crownbio.com/press/first-clinical-candidate-developed-using-hub-organoids-and-high-content-screening-targets-cancer-stem-cells-in-solid-tumors-published-in-nature-cancer?hsLang=en&_ga=2.219502810.2134156882.1651507890-2061451239.1651507890

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.